Search
Alto Neuroscience Inc
ANROAdd to Watchlist
22.600USD
-0.870-3.71%
Close 10-30 16:00（ET）
886.82MMarket Cap
LossP/E TTM
After-hours 19:00 (ET)22.600USD+0.170+0.76%
After-hours 19:00 (ET)ANRO Analyst Recommendation Trends
In the current month, ANRO has received 3 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. ANRO average Analyst price target in the last month is 38.667.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
7
7
7
6
7
7
5
5
3
3
3
3
4
4
4
4
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11
11
11
10
12
12
10
10
Financial Forecasting
Based on analysts' estimates, ANRO EPS is projected to reach -0.674 in FY2026Q3, following reported EPS of -0.646 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.53
-0.54
-0.73
-0.67
-0.70
Actual
-0.47
-0.80
-0.65
--
--
Surprise
+10.82%
-48.66%
+12.12%
--
--
FAQs
How have Alto Neuroscience IncANRO's recent earnings per share performed?
The market expectation was USD -0.65, while Alto Neuroscience IncANRO's earnings per share (EPS) for the previous quarter was USD -0.80. EPS for the next quarter is expected at USD -0.67.
What is the analyst rating for Alto Neuroscience Inc?
Based on the ratings of Alto Neuroscience Inc's stock from 11 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.